peptidebas
antivir
therapeut
gradual
pave
way
mainstream
drug
discoveri
research
experiment
determin
peptid
antivir
activ
express
ic
valu
involv
lot
effort
therefor
develop
avpic
pred
regressionbas
algorithm
predict
antivir
activ
term
ic
valu
lm
total
nonredund
peptid
avpdb
hipdb
divid
trainingtest
set
peptid
valid
set
independ
peptid
v
evalu
util
import
peptid
sequenc
featur
like
aminoacid
composit
binari
profil
residu
physicochem
properti
hybrid
four
differ
machin
learn
techniqu
mlt
name
support
vector
machin
random
forest
instancebas
classifi
kstar
employ
cross
valid
achiev
maximum
pearson
correl
coeffici
pcc
respect
mlt
use
best
combin
featur
set
predict
model
also
perform
well
independ
valid
dataset
achiev
maximum
pcc
respect
best
combin
featur
set
avpic
pred
web
server
anticip
assist
research
work
antivir
therapeut
enabl
comput
screen
mani
compound
focu
experiment
valid
promis
set
peptid
thu
reduc
cost
time
effort
server
avail
http
v
c
wiley
period
inc
biopolym
pept
sci
ntivir
peptid
avp
recent
emerg
altern
strategi
fight
diseas
caus
virus
peptid
enfuvirtid
first
avp
approv
fda
hiv
similarli
sifuvirtid
sft
peptid
shown
potent
antihiv
activ
pharmacokinet
profil
phaseii
clinic
trial
peptid
shown
potenc
human
papilloma
viru
hpv
infect
phase
ii
clinic
trial
peptidebas
ctl
epitop
capabl
induc
cellular
humor
respons
phase
clinic
trial
hepat
c
viru
hcv
anoth
synthet
peptid
report
prevent
hiv
infect
evalu
antivir
properti
phase
ii
clinic
trial
sinc
peptid
involv
number
cellular
process
consider
potenti
act
drug
treat
human
diseas
mani
peptidebas
drug
alreadi
gener
billion
dollar
annual
sale
peptidebas
drug
like
penicillin
insulin
wide
use
therapeut
antimicrobi
peptid
produc
live
organ
mean
defens
invad
microb
includ
bacteria
protozoa
fungi
virus
exampl
cathelicidin
defensin
histatin
forth
late
antimicrobi
peptid
use
control
differ
type
pathogen
particularli
virus
major
caus
malais
death
world
high
genet
variat
differ
rout
transmiss
effici
replic
capabl
persist
host
cell
although
sever
tradit
antivir
nucleosid
nonnucleosid
analogu
virus
mani
drug
undesir
toxic
effect
wherea
avp
natur
amino
acid
lesser
toxic
easili
elimin
bodi
avp
block
virus
via
differ
strategi
includ
inhibit
viru
fusion
signal
replic
forth
interact
variou
glycosaminoglycan
cell
surfac
thu
compet
viru
attach
site
may
obstruct
viral
entri
bind
viru
fusion
protein
cellular
receptor
need
viru
intern
also
hinder
viral
gene
express
translat
via
inhibit
essenti
viral
protein
like
polymeras
revers
transcriptas
forth
earliest
report
avp
describ
herp
simplex
viru
hsv
daher
report
adefensin
avp
hsv
melittin
peptid
note
inhibitori
activ
hiv
junin
viru
jv
similarli
alloferon
peptid
demonstr
inhibit
influenza
viru
peptid
deriv
human
lactoferricin
shown
possess
potent
antivir
activ
varieti
virus
gener
efficaci
avp
measur
half
maxim
inhibitori
concentr
ic
quantit
measur
signifi
concentr
molecul
drug
requir
block
given
biolog
process
half
exampl
flupep
block
influenza
viru
entri
cell
ic
lm
also
peptid
deriv
rhoa
protein
restrict
respiratori
syncyti
viru
rsv
replic
best
perform
peptid
accomplish
ic
lm
similarli
pinon
et
al
abl
inhibit
human
tcell
leukemia
viru
htlv
proteas
use
avp
minimum
ic
lm
also
ray
et
al
demonstr
abil
small
peptid
inhibit
hcv
translat
well
replic
disrupt
interact
proteas
hcv
ire
ic
valu
lm
although
avp
two
special
databas
hipdb
hiv
avpdb
virus
avail
addit
avp
predict
algorithm
avppr
classifi
given
peptid
sequenc
effect
noneffect
also
exist
howev
peptid
antivir
activ
predictor
term
ic
valu
lack
therefor
studi
develop
regressionbas
algorithm
avpic
pred
use
experiment
proven
dataset
employ
multipl
machin
learn
algorithm
peptid
featur
use
differ
featur
like
amino
acid
composit
binari
profil
physicochem
properti
solvent
access
secondari
structur
hybrid
model
develop
addit
also
use
databas
scan
techniqu
display
earlier
report
sequenc
match
user
provid
peptid
amino
acid
composit
amino
acid
composit
wide
use
number
exist
predict
method
fraction
amino
acid
peptid
fraction
natur
amino
acid
calcul
use
follow
equat
fraction
amino
acid
number
xpeptid
length
model
develop
use
mono
di
amino
acid
composit
term
mono
di
respect
binari
profil
mani
research
use
binari
method
predict
protein
peptid
belong
differ
class
binari
profil
gener
peptid
amino
acid
repres
vector
dimens
eg
ala
cy
etc
incorpor
posit
inform
amino
acid
peptid
pattern
window
length
w
repres
qureshi
tandon
kumar
vector
dimens
w
model
creat
employ
binari
pattern
eight
carboxi
eight
amino
termin
amino
acid
refer
bin
bin
respect
gener
binari
pattern
eight
amino
acid
residu
sinc
minimum
length
peptid
dataset
physicochem
properti
number
worker
demonstr
import
physicochem
properti
develop
differ
type
predict
model
use
numer
valu
best
perform
physicochem
properti
support
inform
tabl
aaindex
databas
indic
defin
variou
physico
biochem
properti
amino
acid
pair
amino
acid
model
develop
use
physicochem
featur
denot
physico
solvent
access
solvent
access
peptid
determin
extent
interact
solvent
proport
surfac
area
expos
peptid
solvent
access
peptid
predict
use
method
asaview
model
develop
use
solvent
access
featur
denot
sa
secondari
structur
secondari
structur
peptid
depict
hydrogenbond
pattern
ahelix
bsheet
random
coil
backbon
secondari
structur
peptid
calcul
use
predict
psspred
modul
http
zhanglabccmbmedumich
edupsspr
itass
platform
model
develop
use
secondari
structur
featur
denot
ss
databas
scan
sinc
sequenc
high
resembl
mimic
structur
function
similar
search
may
use
identifi
avp
approach
frequent
use
develop
protein
peptidebas
predict
method
method
queri
sequenc
match
two
newli
releas
avp
databas
viz
avpdb
hipdb
use
blast
machin
learn
techniqu
support
vector
machin
svm
use
develop
number
bioinformat
algorithm
svm
light
softwar
packag
avail
http
svmlightjoachimsorg
use
construct
svm
model
studi
use
radial
basi
function
kernel
x
two
data
vector
c
train
paramet
random
forest
random
forest
rf
ensembl
learn
method
classif
regress
randomforest
packag
version
r
avail
http
statwwwberkeleyeduus
breimanrandomforest
use
ibk
ibk
knearest
neighbor
classifi
avail
weka
packag
access
http
wwwcswaikatoacnzmlweka
select
appropri
valu
k
base
crossvalid
distanc
weight
valu
test
instanc
base
upon
valu
train
instanc
similar
determin
similar
function
order
evalu
perform
model
use
pearson
correl
coeffici
pcc
model
evalu
use
leav
one
cross
valid
loocv
techniqu
loocv
peptid
dataset
use
test
iter
rest
peptid
use
train
respect
predict
model
addit
loocv
also
use
leav
one
viru
cross
valid
lovocv
method
techniqu
avp
viru
iter
exclud
classifi
train
remain
viru
avp
follow
test
exclud
avp
individu
viru
avpic
pred
model
develop
use
variou
peptid
sequenc
featur
includ
mono
diamino
acid
composit
binari
pattern
eight
ctermin
ntermin
amino
acid
physicochem
properti
forth
cross
valid
use
svm
achiev
maximum
correl
mono
di
physico
solvent
access
sa
secondari
structur
ss
model
respect
train
test
dataset
use
hybrid
model
mention
featur
perform
improv
maximum
case
monodiphysicosass
composit
featur
shown
tabl
svm
rf
paramet
use
develop
predict
model
shown
support
inform
tabl
furthermor
calcul
pvalu
differ
model
found
pvalu
model
statist
signific
model
pvalu
also
use
machin
learn
algorithm
like
rf
ibk
k
check
perform
train
test
data
use
mention
featur
rf
perform
similar
svm
best
pcc
hybrid
model
ibk
k
show
best
perform
hybrid
featur
tabl
howev
svm
perform
better
machin
learn
algorithm
besid
cross
valid
also
check
perform
model
independ
dataset
peptid
v
use
trainingtest
achiev
maximum
correl
mono
di
physico
solvent
access
sa
secondari
structur
ss
model
respect
use
svm
expect
hybrid
model
gave
better
correl
maximum
pcc
valu
hybrid
monodiphysicosass
model
model
use
svm
machin
learn
techniqu
mlt
perform
similar
trend
correl
less
compar
svm
best
correl
hybrid
monodiphysicosass
model
rf
ibk
k
tabl
correl
actual
predict
ic
valu
independ
dataset
use
svm
rf
also
graphic
depict
figur
check
predict
perform
viru
avp
dataset
use
lovocv
method
tabl
ii
overal
train
dataset
perform
cross
valid
rang
pcc
valu
minimum
maximum
averag
simultan
valid
perform
rang
pcc
averag
method
show
good
correl
virus
howev
virus
like
hiv
rsv
infv
hsv
perform
satisfactori
sinc
enough
avp
rsv
infv
hsv
avail
therefor
made
combin
dataset
virus
develop
predict
model
best
pcc
use
loocv
model
perform
well
pcc
independ
dataset
three
virus
also
develop
viru
specif
model
hiv
hcv
reason
number
peptid
avail
also
check
perform
method
use
loocv
techniqu
employ
earlier
mention
peptid
sequenc
featur
tabl
iii
method
use
specif
avp
dataset
belong
hiv
avp
hcv
avp
individu
divid
train
valid
dataset
keep
data
valid
case
also
perform
increas
use
hybrid
monodiphysico
bin
featur
pcc
compar
individu
featur
pcc
two
sampl
logo
use
graphic
depict
differ
two
set
sequenc
align
webbas
tool
freeli
avail
via
url
http
wwwtwosamplelogo
org
highli
least
effect
avp
chosen
gener
two
sampl
logo
use
ntermin
ctermin
residu
ic
valu
highli
least
effect
avp
mm
mm
respect
n
termin
region
found
larg
acid
amino
acid
like
met
thr
asp
glu
enrich
highli
effect
avp
small
basic
amino
acid
like
ala
gli
ly
common
least
effect
avp
figur
similarli
ctermin
region
larg
polar
nonpolar
amino
acid
like
leu
trp
asn
frequent
highli
effect
avp
small
posit
charg
amino
acid
like
gli
ly
arg
common
least
effect
avp
figur
two
sampl
logo
sequenc
differ
amino
acid
color
per
charg
hydrophob
surfac
exposur
flexibl
disord
avail
support
inform
figur
box
plot
conveni
way
denot
summari
statist
distribut
numer
data
allow
depict
maximum
minimum
median
data
set
also
visual
lower
upper
quartil
select
highli
effect
ic
mm
equal
number
least
effect
avp
ic
mm
calcul
best
perform
physicochem
properti
support
inform
tabl
predict
svm
box
plot
individu
properti
drawn
use
boxplotr
avail
http
boxplottyerslabcom
plot
shown
support
inform
figur
ii
observ
properti
like
helix
initi
paramet
c
frequenc
ctermin
non
beta
region
free
energi
betastrand
region
e
frequenc
helix
f
k
discrimin
compar
other
similar
result
avpic
pred
web
server
freeli
access
via
url
http
flowchart
depict
workflow
avpic
pred
web
server
shown
support
inform
figur
input
submit
page
user
may
past
singl
multipl
peptid
sequenc
fasta
format
provid
textbox
upload
fasta
file
system
exampl
link
provid
load
default
set
sequenc
user
select
desir
model
mlt
run
predict
support
inform
figur
output
predict
output
shown
tabular
form
column
first
second
third
column
consist
sequenc
identifi
input
fasta
sequenc
sequenc
sequenc
length
respect
fourth
column
give
action
button
databas
scan
order
check
presenc
similar
sequenc
exist
antivir
databas
hipdb
avpdb
also
latest
uniprot
releas
use
blast
rest
column
show
output
differ
mlt
use
studi
svm
rf
ibk
k
predict
ic
valu
peptid
sequenc
display
lm
unit
analysi
column
display
calcul
physicochem
properti
peptid
question
column
tabl
provid
sort
function
search
option
also
provid
filter
result
figur
mutat
analyz
tool
allow
user
gener
possibl
combin
amino
acid
mutat
given
peptid
sequenc
predict
ic
mutant
peptid
use
best
perform
model
howev
mutat
peptid
comput
predict
need
experiment
valid
work
exampl
provid
tabl
iv
avpic
predblast
user
may
blast
peptid
similar
hipdb
avpdb
result
show
distribut
hit
score
evalu
align
sequenc
signific
similar
avpic
predmap
map
tool
use
fetch
perfectli
match
peptid
avail
exist
avp
databas
physicochem
properti
calcul
properti
tool
allow
user
visual
examin
import
peptid
featur
like
amino
acid
composit
hydrophob
prefer
bstrand
frequenc
ahelix
given
peptid
sequenc
motif
search
avpic
pred
motif
scan
allow
search
possibl
avp
motif
user
provid
proteinpeptid
sequenc
tool
base
mememast
softwar
protein
fragmentor
tool
gener
peptid
fragment
desir
length
overlap
residu
protein
sequenc
avpic
conserv
check
conserv
user
provid
peptid
sequenc
human
viral
antivir
protein
use
avpic
pred
mutat
analyz
user
gener
possibl
combin
amino
acid
mutat
given
peptid
sequenc
predict
ic
mutant
peptid
tool
also
enabl
user
sort
mutant
peptid
per
predict
ic
valu
select
highli
effect
peptid
exampl
gener
mutant
hiv
fusion
inhibitor
use
tool
found
mutat
like
improv
predict
ic
hundr
fold
likewis
mutat
peptid
alter
ic
fold
similar
analysi
peptid
also
carri
provid
tabl
iv
due
limit
avail
drug
vaccin
mani
virus
demand
develop
effect
antivir
therapeut
thu
apart
drug
vaccin
avp
potenti
altern
control
viral
pathogenesi
lower
toxic
broad
rang
avp
eb
peptid
hsv
adefensin
cytomegaloviru
cmv
enfuvirtid
sft
hiv
human
neutrophil
peptid
vsv
forth
shown
promis
result
high
specif
rel
offtarget
sideeffect
avp
act
via
varieti
rout
includ
inhibit
viral
entri
host
cell
suppress
viral
gene
express
translat
immunopotenti
forth
antivir
activ
peptid
often
determin
experiment
half
maxim
inhibitori
concentr
ic
valu
usual
avp
mm
ic
valu
consid
effect
lm
least
effect
repress
viral
process
function
although
mani
antimicrobi
peptid
predict
server
like
camp
wang
et
al
forth
one
avp
predictor
avppr
base
classif
mode
machin
learn
classifi
peptid
sequenc
effect
ineffect
addit
none
quantit
predict
antimicrobi
antivir
activ
peptid
term
ic
develop
predictor
extract
comprehens
nonredund
avp
quantit
ic
valu
special
resourc
hipdb
avpdb
avp
randomli
divid
three
trainingtest
valid
dataset
belong
mani
medic
import
virus
also
check
perform
svm
model
base
three
train
valid
dataset
select
one
set
better
perform
algorithm
develop
shown
support
inform
tabl
peptidebas
antivir
act
mani
differ
way
howev
gener
avp
act
via
interfer
proteinprotein
interact
mimick
properti
one
interfac
thu
act
competit
inhibitor
prevent
interact
bind
protein
partner
variou
sequenc
featur
peptid
play
import
role
bioactiv
featur
includ
amino
acid
composit
n
c
termin
residu
physicochem
properti
like
hydrophob
secondari
structur
forth
also
report
previous
predict
import
peptid
viz
abcpr
anticp
qsppred
forth
evan
et
al
also
describ
hiv
coreceptor
tropism
predict
basi
aminoacid
site
physiochem
characterist
loop
sequenc
hiv
envelop
result
howev
found
svm
rf
compar
perform
better
ibk
k
mlt
mlt
svm
choos
appropri
kernel
gener
grade
svm
gain
flexibl
robust
deliv
uniqu
solut
predict
rf
comput
proxim
pair
case
use
cluster
locat
outlier
rf
fast
highli
accur
learn
algorithm
handl
thousand
input
variabl
without
variabl
delet
ibk
k
simpl
mlt
work
well
basic
recognit
problem
one
shortcom
two
algorithm
lazi
learner
learn
anyth
train
data
simpli
use
train
data
predict
robust
predict
noisi
data
due
reason
svm
rf
perform
better
mlt
studi
avpic
pred
regressionbas
algorithm
employ
hybrid
model
integr
differ
peptid
featur
like
amino
acid
composit
binari
profil
physicochem
properti
forth
claim
method
first
ever
attempt
predict
numer
antivir
efficaci
valu
given
peptid
use
svm
first
place
predict
peptid
ic
valu
achiev
maximum
pcc
cross
valid
pcc
independ
dataset
sinc
avp
heterogen
term
target
virus
one
import
question
remain
whether
algorithm
applic
gener
virus
found
earlier
research
given
class
peptid
follow
certain
pattern
case
antimicrobi
peptid
predict
algorithm
like
camp
classamp
ampa
forth
address
issu
use
lovocv
strategi
avp
viru
iter
exclud
classifi
train
avp
remain
virus
follow
test
exclud
avp
approach
work
virus
predict
perform
ic
viru
satisfactori
virus
despit
fact
data
includ
train
show
avpic
pred
act
gener
avp
predict
algorithm
may
appli
virus
well
howev
except
like
hiv
rsv
infv
hsv
algorithm
work
due
fact
virus
differ
manner
infectionlif
cycl
henc
mechan
mode
action
avp
may
differ
case
therefor
provid
viru
specif
model
virus
also
integr
web
server
futur
interest
make
target
specif
algorithm
appropri
enough
data
avail
report
literatur
predict
method
develop
regress
mode
show
lower
correl
heterogen
dataset
homogen
dataset
exampl
similar
studi
sirna
found
pcc
rang
heterogen
dataset
increas
homogen
dataset
svm
model
studi
develop
use
highli
divers
dataset
taken
differ
studi
test
cell
line
virus
pcc
regress
mode
reason
perform
improv
larg
homogen
dataset
avail
futur
howev
put
confid
present
predict
use
three
mlt
addit
svm
name
rf
ibk
k
perform
similar
fashion
also
encourag
develop
newer
regressionbas
algorithm
besid
exist
classificationbas
method
area
peptidebas
therapeut
limit
report
experiment
improv
ic
valu
avp
overcom
viru
resist
amino
acid
substitut
izumi
et
al
design
enfuvirtid
variant
contain
substitut
show
potent
inhibitor
enfuvirtid
sensit
enfuvirtid
resist
virus
also
shown
mutat
four
ctermin
amino
acid
wnwf
anaa
enfuvirtid
peptid
made
inact
dwyer
et
al
found
mutat
increas
peptid
helic
structur
effect
block
viru
improv
peptid
efficaci
achiev
consider
effort
term
time
cost
algorithm
gener
possibl
mutant
potenti
avp
predict
efficaci
result
might
achiev
lesser
time
simultan
avp
improv
efficaci
might
use
mutat
virus
assist
research
direct
avpic
pred
mutat
analyz
tool
use
design
avp
enhanc
antivir
potenti
illustr
applic
section
predict
analysi
ic
singl
mutant
avp
dataset
provid
web
server
besid
avpic
pred
web
server
also
equip
import
tool
physicochem
properti
calcul
motif
scan
blast
conserv
map
fragment
tool
analysi
avp
pred
first
regressionbas
algorithm
develop
use
experiment
valid
data
set
predict
peptid
antivir
activ
term
ic
multipl
mlt
use
build
comprehens
predict
model
exploit
import
peptid
sequenc
featur
amino
acid
dipeptid
composit
binari
profil
residu
well
select
physicochem
properti
avpic
pred
web
server
hope
assist
research
work
avp
therapeut
decreas
cost
time
effort
involv
experiment
valid
mk
conceiv
approach
help
analysi
interpret
data
gave
overal
supervis
project
mk
aq
wrote
manuscript
aq
ht
collect
data
implement
machin
learn
softwar
develop
web
server
author
read
approv
final
manuscript
author
declar
compet
interest
